"Het Dijklander Ziekenhuis wil een ziekenhuis zijn waar u zich welkom voelt. Een ziekenhuis waar het niet alleen draait om de vraag ‘wat is er met u’ maar ook om ‘wat is voor u belangrijk?’ Wij willen onze patiënten écht begrijpen. We zijn geworteld in de regio’s Waterland en West-Friesland en bieden zorg aan al hun inwoners. Als opleidingsziekenhuis delen we kennis en ervaring. Het houdt ons scherp en zo blijven we ons ontwikkelen. Samenwerking met andere partijen zoals (academische) ziekenhuizen, huisartsen en thuiszorg vinden wij voor goede zorg onmisbaar."

During the past decade, Westfries Gasthuis conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 3 clinical trials were completed, i.e. on average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Westfries Gasthuis" #1 sponsor was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 4 trials, followed by "The Netherlands Cancer Institute" with 4 trials sponsored, "Dutch Colorectal Cancer Group" with 3 trials sponsored, "Radboud University Medical Center" with 3 trials sponsored and "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Westfries Gasthuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 6 trials as a collaborator, "Borstkanker Onderzoek Groep" with 3 trials as a collaborator, "Amsterdam UMC, location VUmc" with 2 trials as a collaborator, "Dutch Digestive Diseases Foundation" with 2 trials as a collaborator and "Erasmus Medical Center" with 2 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Westfries Gasthuis" are "Breast Cancer" (4 trials), "Atrial Fibrillation" (3 trials), "Colorectal Cancer" (3 trials), "Abdominal Aortic Aneurysm" (2 trials) and "Cancer" (2 trials). Many other conditions were trialed in "Westfries Gasthuis" in a lesser frequency.

Most popular intervention types in "Westfries Gasthuis" are "Drug" (21 trials), "Other" (11 trials), "Procedure" (8 trials), "Device" (5 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Bevacizumab" (2 trials), "bococizumab (PF-04950615)" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials) and "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Westfries Gasthuis" are 37 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Westfries Gasthuis". undefined are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Westfries Gasthuis, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Westfries Gasthuis, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 11 trials that are defined as “Not Applicable".